Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.

GTPase Kras (KRAS) GTPase-activating protein (GAP) NF1 Ras protein cancer cell signaling dimerization mitogen-activated protein kinase pathway neurofibromin

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
24 01 2020
Historique:
received: 03 09 2019
revised: 10 12 2019
pubmed: 15 12 2019
medline: 5 9 2020
entrez: 15 12 2019
Statut: ppublish

Résumé

Neurofibromin is a tumor suppressor encoded by the

Identifiants

pubmed: 31836666
pii: S0021-9258(17)49919-4
doi: 10.1074/jbc.RA119.010934
pmc: PMC6983858
doi:

Substances chimiques

Neurofibromin 1 0
ras GTPase-Activating Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1105-1119

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197709
Pays : United States

Informations de copyright

© 2020 Sherekar et al.

Références

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775
pubmed: 27791178
Cell. 1990 Nov 16;63(4):843-9
pubmed: 2121370
EMBO Rep. 2006 Feb;7(2):174-9
pubmed: 16397625
Acta Pharmacol Sin. 2018 Dec;39(12):1837-1846
pubmed: 29991711
Hum Mutat. 2011 Feb;32(2):191-7
pubmed: 21089070
Protein Expr Purif. 2009 May;65(1):30-7
pubmed: 19111619
Leukemia. 2018 Dec;32(12):2536-2545
pubmed: 29872168
J Biotechnol. 2016 Nov 20;238:1-8
pubmed: 27616621
Nat Genet. 2015 Sep;47(9):996-1002
pubmed: 26214590
FEBS Lett. 1996 Mar 11;382(1-2):53-9
pubmed: 8612763
Anal Biochem. 2013 Jun 1;437(1):104-8
pubmed: 23458356
Somat Cell Mol Genet. 1993 May;19(3):265-74
pubmed: 8332934
Sci Rep. 2018 Apr 18;8(1):6171
pubmed: 29670214
Biophys J. 2000 Mar;78(3):1606-19
pubmed: 10692345
J Struct Biol. 2007 Jan;157(1):38-46
pubmed: 16859925
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Appl Crystallogr. 2017 Jun 26;50(Pt 4):1212-1225
pubmed: 28808438
J Invest Dermatol. 2006 Mar;126(3):653-9
pubmed: 16374483
Mol Cell Biol. 2010 May;30(9):2264-79
pubmed: 20160012
J Vis Exp. 2017 May 16;(123):
pubmed: 28570515
Biochem Biophys Res Commun. 2006 Feb 24;340(4):1200-8
pubmed: 16405917
J Biol Chem. 2002 Oct 4;277(40):36909-12
pubmed: 12191989
Brain Res Dev Brain Res. 2001 Oct 24;130(2):231-48
pubmed: 11675125
Lab Invest. 2017 Feb;97(2):146-157
pubmed: 28067895
Hum Genomics. 2017 Jun 21;11(1):13
pubmed: 28637487
Genes Dev. 2012 Jul 1;26(13):1421-6
pubmed: 22751498
J Cell Sci. 2016 Nov 1;129(21):3963-3970
pubmed: 27802131
Biophys J. 2005 Jul;89(1):619-34
pubmed: 15863475
Curr Protoc Protein Sci. 2013 Feb;Chapter 20:Unit20.12
pubmed: 23377850
Clin Cancer Res. 2016 Jul 1;22(13):3148-56
pubmed: 26861459
Biophys J. 2019 Mar 19;116(6):1049-1063
pubmed: 30846362
Methods Cell Biol. 2008;84:143-79
pubmed: 17964931
Methods Mol Biol. 2017;1586:65-82
pubmed: 28470599
Nature. 2013 Apr 25;496(7446):477-81
pubmed: 23619693
Science. 1990 Jul 13;249(4965):181-6
pubmed: 2134734
Methods Enzymol. 2000;328:575-92
pubmed: 11075367
Genes (Basel). 2019 Aug 28;10(9):
pubmed: 31466283
Oncogene. 1994 Feb;9(2):597-601
pubmed: 8290270
Hum Mol Genet. 2015 Jun 15;24(12):3518-28
pubmed: 25788518
Hum Genet. 1997 Jan;99(1):88-92
pubmed: 9003501
Genes (Basel). 2019 Jan 23;10(2):
pubmed: 30678108
EMBO J. 1998 Aug 3;17(15):4313-27
pubmed: 9687500

Auteurs

Mukul Sherekar (M)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Sae-Won Han (SW)

Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94158.
Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.

Rodolfo Ghirlando (R)

Laboratory of Molecular Biology, NIDDK, National Institutes of Health, Bethesda, Maryland 20892.

Simon Messing (S)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Matthew Drew (M)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Dana Rabara (D)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Timothy Waybright (T)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Puneet Juneja (P)

Robert P. Apkarian Integrated Electron Microscopy Core, Emory University, Atlanta, Georgia 30322.

Hugh O'Neill (H)

Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830.

Christopher B Stanley (CB)

Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830.

Debsindhu Bhowmik (D)

Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830.

Arvind Ramanathan (A)

Argonne National Laboratory, Lemont, Illinois 60439.

Sriram Subramaniam (S)

Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.
Department of Biochemistry, Life Sciences Center, University of British Columbia, Vancouver, British Columbia V6T1Z3, Canada.

Dwight V Nissley (DV)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

William Gillette (W)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.

Frank McCormick (F)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702.
Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94158.

Dominic Esposito (D)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702 dom.esposito@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH